Xiamen Kingdomway Group: Announcement on Obtaining Invention Patent Certificate
Xiamen Kingdomway Group: Announcement regarding the administrative penalty decision received by the wholly-owned subsidiary
Xiamen Kingdomway Group: 002626 Xiamen Kingdomway Group Investor Relations Management Information on July 2, 2024.
Xiamen Kingdomway Group: Announcement regarding wholly-owned subsidiary obtaining food production license.
Xiamen Kingdomway Group: Announcement on Obtaining Invention Patent Certificate
Xiamen Kingdomway Group: Announcement on the progress of holding subsidiary Doctor's Best Inc.'s acquisition of 100% equity of Activ Nutritional, LLC.
Xiamen Kingdomway Group: 2023 Annual Equity Distribution Implementation Notice
Xiamen Kingdomway Group: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Xiamen Kingdomway Group: Legal Opinion of the 2023 Annual General Meeting of Shareholders
Xiamen Kingdomway Group: 002626 Jindaway Investor Relations Management Information 20240521
Xiamen Kingdomway Group: 002626 Jindaway Investor Relations Management Information 20240520
Xiamen Kingdomway Group: Notice on Obtaining an Invention Patent Certificate
Xiamen Kingdomway Group: 002626 Jindaway Investor Relations Management Information 20240516
Xiamen Kingdomway Group: 4-1 Legal Opinion (Declaration Draft)
Xiamen Kingdomway Group: 3-3 Listing Sponsorship Letter (Application Draft)
Xiamen Kingdomway Group: 1-1 Recruiting Instructions (Application Draft)
Xiamen Kingdomway Group: 6-1 The issuer's financial report for the last three years, its audit report, and the most recent financial report (declaration draft)
Xiamen Kingdomway Group: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)
Xiamen Kingdomway Group: Response from Lixin Certified Public Accountants (Special General Partnership) to the review inquiry letter of Xiamen Jindaway Group Co., Ltd.'s application to issue convertible corporate bonds to unspecified targets
Xiamen Kingdomway Group: Report of GF Securities Co., Ltd. on the review inquiry letter of Xiamen Jindaway Group Co., Ltd.'s application to issue convertible corporate bonds to unspecified targets
No Data